| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.012 | 3.563 | 7.662 | 4.513 | 10.011 | 5.045 | 7.075 | 7.604 | 9.704 | 14.917 |
| Total Income - EUR | 1.012 | 3.563 | 7.662 | 4.513 | 10.011 | 5.045 | 7.075 | 7.604 | 9.704 | 14.924 |
| Total Expenses - EUR | 2.823 | 1.915 | 2.792 | 3.639 | 2.081 | 513 | 1.249 | 2.713 | 2.969 | 14.672 |
| Gross Profit/Loss - EUR | -1.811 | 1.648 | 4.870 | 874 | 7.930 | 4.532 | 5.826 | 4.891 | 6.735 | 252 |
| Net Profit/Loss - EUR | -1.841 | 1.541 | 4.640 | 795 | 7.629 | 4.380 | 5.614 | 4.667 | 5.674 | 121 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Intermed Pharmprod & Trade Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 9 | 31 | 236 | 738 | 4.202 | 8.476 | 8.268 | 6.420 | 8.557 | 5.012 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 2.108 | 4.135 | 4.043 | 4.056 | 4.043 | 3.677 |
| Cash | 9 | 31 | 236 | 738 | 2.094 | 4.341 | 4.225 | 2.364 | 4.513 | 1.335 |
| Shareholders Funds | -1.915 | -354 | -86 | 710 | 4.111 | 8.414 | 8.180 | 6.352 | 8.165 | 4.219 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.924 | 385 | 322 | 28 | 90 | 62 | 88 | 68 | 392 | 792 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Intermed Pharmprod & Trade Srl